Want to see PPCB full AI Analyst Report?
Propanc Biopharma (PPCB) Q1 2026 Earnings Report
PPCB Q1 2026 EPS Results
- Actual EPS
- -$98.08
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$8,998.20
PPCB Q1 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 11/17/2025
- Time
- Before Open
- Conference Call
- Monday, November 17, 2025
PPCB Upcoming Earnings
Propanc Biopharma's next earnings date is estimated for November 23, 2026, based on past reporting schedules.
Q1 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
PPCB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 23, 2026 | 2027 (Q1) | ―- | -9.81 | ― | ― |
| Sep 29, 2026 | 2026 (Q4) | ―-13.81 | -87.66 | 84.24% (+73.84) | |
| May 15, 2026 | 2026 (Q3) | ―-70.90 | -3124.56 | 97.73% (+3053.66) | |
| Feb 18, 2026 | 2026 (Q2) | ―-75.29 | -8248.35 | 99.09% (+8173.06) | |
| Nov 17, 2025 | 2026 (Q1) | ―-98.08 | -8998.2 | 98.91% (+8900.12) | |
| May 15, 2020 | 2020 (Q3) | ―-348780.00 | -895000 | 61.03% (+546220.00) | |
| Feb 14, 2020 | 2020 (Q2) | ―-1250780.00 | -41335000 | 96.97% (+40084220.00) | |
| Nov 14, 2019 | 2019 (Q4) | ―-1414920.00 | -9445000 | 85.02% (+8030080.00) | |
| Nov 14, 2019 | 2020 (Q1) | ―- | -9445 | ― | |
| May 15, 2019 | 2019 (Q3) | ―-895.00 | -30000 | 97.02% (+29105.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed